Amit K. Verma, MD

Articles by Amit K. Verma, MD

CD19 CAR T-Cell Therapy Shows Efficacy in Real-World Setting

April 22nd 2020

Investigators at Montefiore showed that axicabtagene-ciloleucel can be used successfully in ethnically diverse patients with high-risk, relapsed/refractory diffuse large B-cell lymphoma at an inner-city hospital.

Latest Updated Articles

CD19 CAR T-Cell Therapy Shows Efficacy in Real-World Setting
Published: April 22nd 2020 | Updated:

Amit K. Verma, MD

Articles by Amit K. Verma, MD

CD19 CAR T-Cell Therapy Shows Efficacy in Real-World Setting

Latest Updated Articles

Trending on CGTlive®

AAVantgarde’s Stargardt Gene Therapy AAVB-039 Garners FDA Orphan Drug Designation, Cleared for Trial in UK

Around the Helix: Cell and Gene Therapy Company Updates – October 22, 2025

AskBio’s Heart Failure Gene Therapy AB-1002 Shows Ability to Improve NYHA Class in Phase 1 Trial